Abstract: Reasons for a Risk Assessment on Drug Residues in Milk and Milk Products From an Industry and FDA Perspective (2012 Annual Meeting)

Reasons for a Risk Assessment on Drug Residues in Milk and Milk Products From an Industry and FDA Perspective

Monday, July 23, 2012: 1:30 PM

Room 551 (Rhode Island Convention Center)

Roger Hooi, Morningstar Foods/Dean Foods, Dallas, TX

John Sheehan, U.S. Food and Drug Administration-CFSAN, College Park, MD

Recorded Presentation